Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alphanate safety in severe hemophilia A
NCT00323856Phase 4Completed
- Sponsor
- Grifols
- Start
- Apr 2003
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of coagulation factor IX human in hemophilia A, sponsored by Grifols. Started Apr 2003; status: completed.
02
Drugs
coagulation factor IX human
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00323856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323856.